Definitive Contract HHSN272201700004C
Award Date
1/31/17
Potential Completion Date
1/31/24
Potential Value
$141M
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
PPD Development LP
Ultimate Awardee
Not listed
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
PSC Category
AN81 - R&D- Medical: Aids Research (Basic Research)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Cape Fear, NC 28401, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
4
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a cost-plus-fixed-fee definitive contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to PPD Development LP, a global contract research organization (CRO), for R&D services related to biomedical basic research. The $27,437,431.92 contract has a performance period ending on October 31, 2021 and is not set aside for any specific business type. PPD Development LP has been awarded over $500 million in prime federal...
This is a $28,578,960 definitive, cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to PPD Development LP, a global contract research organization and subsidiary of Thermo Fisher Scientific. The contract is for clinical site monitoring services in support of NIAID's various clinical research programs, trials, and studies. It has a 10-year period of performance and was awarded on a full and open basis without a set-aside designation. The...
This is a cost-plus-award-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to PPD Development LP, a global contract research organization (CRO). The contract, titled "NIAID HIV and Other Infectious Diseases Clinical Research Support Services (CRSS)", has a ceiling value of $342,278,815.66 and a period of performance ending on August 15, 2024. The contract was awarded...
This is a $75,173,993.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to PPD Development LP, a global contract research organization (CRO) and subsidiary of Thermo Fisher Scientific. The contract provides comprehensive and rapid response services for NIAID's research programs related to HIV and other infectious diseases. This order falls under a larger $545 million Comprehensive and Rapid Response contract vehicle that...
This is a $5,758,524.34 delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to PPD Development LP, a global contract research organization (CRO). The contract is to provide monitoring services for a Phase III clinical trial, specifically trial A5300B/PHOENIX. It is a cost-plus-fixed-fee contract with an ultimate completion date of December 14, 2025. The contract was awarded on April 15, 2019 and is not...
This is a $2,791,811.00 delivery order awarded to PPD Development LP by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency. The contract is a task order under the Early Phase Clinical Trial Units (EPCTU) indefinite delivery vehicle, which facilitates Phase 0 through Phase II clinical trials for infectious diseases. As a global contract research organization, PPD Development LP will provide comprehensive services such as clinical site monitoring, regulatory...
This is a $29,120,381 cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to PPD Development LP, a global contract research organization (CRO). The contract is for the Regulatory Management Center (RMC), which provides regulatory affairs support services. This contract has no set-aside designation. The original solicitation was a Sources Sought notice seeking small business capability...
This is a $186,449,775.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to PPD Development LP, a global contract research organization (CRO) and subsidiary of Thermo Fisher Scientific. The contract, titled "NIAID CLINICAL SITE MONITORING (NCSM)", is for clinical site monitoring services with a period of performance through January 31, 2031. This award is under NIAID's $999 million OASIS+...
This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services (HHS), to PPD Development LP, a global contract research organization (CRO). The contract, valued at $64,031,927.00, is for completing the ACTIV 2 study to support COVID-19 research. The contract is a cost-plus-fixed-fee type and does not have a set-aside designation. PPD Development LP is a subsidiary of Thermo Fisher...
This is a firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract, valued at $696,693.16, was awarded to PPD Development LP, a global contract research organization (CRO), to provide PPD development site and study monitoring services. The contract has no set-aside designation and is part of several indefinite delivery...